0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Point of Care Testing for Infectious Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-2L3019
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Point of Care Testing for Infectious Disease Market Insights and Forecast to 2028
BUY CHAPTERS

Point of Care Testing for Infectious Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2L3019
Report
September 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Point of Care Testing for Infectious Disease - Market Size

The global market for Point of Care Testing for Infectious Disease was estimated to be worth US$ 10280 million in 2023 and is forecast to a readjusted size of US$ 13440 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030

Point of Care Testing for Infectious Disease - Market

Point of Care Testing for Infectious Disease - Market

North American market for Point of Care Testing for Infectious Disease was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Point of Care Testing for Infectious Disease was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Point of Care Testing for Infectious Disease was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Point of Care Testing for Infectious Disease include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Point of Care Testing for Infectious Disease, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Point of Care Testing for Infectious Disease by region & country, by Type, and by Application.
The Point of Care Testing for Infectious Disease market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Testing for Infectious Disease.
Market Segmentation

Scope of Point of Care Testing for Infectious Disease - Market Report

Report Metric Details
Report Name Point of Care Testing for Infectious Disease - Market
Forecasted market size in 2030 US$ 13440 million
CAGR 10.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospital
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Sinocare, Wondfo, Yuwell, Runbio, KHB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Point of Care Testing for Infectious Disease manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Point of Care Testing for Infectious Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Point of Care Testing for Infectious Disease in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Point of Care Testing for Infectious Disease - Market size in 2030?

Ans: The Point of Care Testing for Infectious Disease - Market size in 2030 will be US$ 13440 million.

Who are the main players in the Point of Care Testing for Infectious Disease - Market report?

Ans: The main players in the Point of Care Testing for Infectious Disease - Market are Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Sinocare, Wondfo, Yuwell, Runbio, KHB

What are the Application segmentation covered in the Point of Care Testing for Infectious Disease - Market report?

Ans: The Applications covered in the Point of Care Testing for Infectious Disease - Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Point of Care Testing for Infectious Disease - Market report?

Ans: The Types covered in the Point of Care Testing for Infectious Disease - Market report are Immunological Test, Pathogen Nucleic Acid Test

Recommended Reports

Point-of-Care Diagnostics

Infectious Disease Testing

POC Specialized Segments

1 Market Overview
1.1 Point of Care Testing for Infectious Disease Product Introduction
1.2 Global Point of Care Testing for Infectious Disease Market Size Forecast
1.3 Point of Care Testing for Infectious Disease Market Trends & Drivers
1.3.1 Point of Care Testing for Infectious Disease Industry Trends
1.3.2 Point of Care Testing for Infectious Disease Market Drivers & Opportunity
1.3.3 Point of Care Testing for Infectious Disease Market Challenges
1.3.4 Point of Care Testing for Infectious Disease Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Point of Care Testing for Infectious Disease Players Revenue Ranking (2023)
2.2 Global Point of Care Testing for Infectious Disease Revenue by Company (2019-2024)
2.3 Key Companies Point of Care Testing for Infectious Disease Manufacturing Base Distribution and Headquarters
2.4 Key Companies Point of Care Testing for Infectious Disease Product Offered
2.5 Key Companies Time to Begin Mass Production of Point of Care Testing for Infectious Disease
2.6 Point of Care Testing for Infectious Disease Market Competitive Analysis
2.6.1 Point of Care Testing for Infectious Disease Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Point of Care Testing for Infectious Disease Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Testing for Infectious Disease as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunological Test
3.1.2 Pathogen Nucleic Acid Test
3.2 Global Point of Care Testing for Infectious Disease Sales Value by Type
3.2.1 Global Point of Care Testing for Infectious Disease Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Point of Care Testing for Infectious Disease Sales Value, by Type (2019-2030)
3.2.3 Global Point of Care Testing for Infectious Disease Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Others
4.2 Global Point of Care Testing for Infectious Disease Sales Value by Application
4.2.1 Global Point of Care Testing for Infectious Disease Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Point of Care Testing for Infectious Disease Sales Value, by Application (2019-2030)
4.2.3 Global Point of Care Testing for Infectious Disease Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Point of Care Testing for Infectious Disease Sales Value by Region
5.1.1 Global Point of Care Testing for Infectious Disease Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Point of Care Testing for Infectious Disease Sales Value by Region (2019-2024)
5.1.3 Global Point of Care Testing for Infectious Disease Sales Value by Region (2025-2030)
5.1.4 Global Point of Care Testing for Infectious Disease Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Point of Care Testing for Infectious Disease Sales Value, 2019-2030
5.2.2 North America Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Point of Care Testing for Infectious Disease Sales Value, 2019-2030
5.3.2 Europe Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Point of Care Testing for Infectious Disease Sales Value, 2019-2030
5.4.2 Asia Pacific Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Point of Care Testing for Infectious Disease Sales Value, 2019-2030
5.5.2 South America Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Point of Care Testing for Infectious Disease Sales Value, 2019-2030
5.6.2 Middle East & Africa Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value
6.3 United States
6.3.1 United States Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.3.2 United States Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.4.2 Europe Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.5.2 China Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.5.3 China Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.6.2 Japan Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.7.2 South Korea Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.8.2 Southeast Asia Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Point of Care Testing for Infectious Disease Sales Value, 2019-2030
6.9.2 India Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
6.9.3 India Point of Care Testing for Infectious Disease Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Point of Care Testing for Infectious Disease Products, Services and Solutions
7.1.4 Roche Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Point of Care Testing for Infectious Disease Products, Services and Solutions
7.2.4 Abbott Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 LifeScan
7.3.1 LifeScan Profile
7.3.2 LifeScan Main Business
7.3.3 LifeScan Point of Care Testing for Infectious Disease Products, Services and Solutions
7.3.4 LifeScan Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.3.5 Siemens Healthineers Recent Developments
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Profile
7.4.2 Siemens Healthineers Main Business
7.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Products, Services and Solutions
7.4.4 Siemens Healthineers Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.4.5 Siemens Healthineers Recent Developments
7.5 Danaher
7.5.1 Danaher Profile
7.5.2 Danaher Main Business
7.5.3 Danaher Point of Care Testing for Infectious Disease Products, Services and Solutions
7.5.4 Danaher Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Recent Developments
7.6 Ascensia
7.6.1 Ascensia Profile
7.6.2 Ascensia Main Business
7.6.3 Ascensia Point of Care Testing for Infectious Disease Products, Services and Solutions
7.6.4 Ascensia Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.6.5 Ascensia Recent Developments
7.7 BioMerieux
7.7.1 BioMerieux Profile
7.7.2 BioMerieux Main Business
7.7.3 BioMerieux Point of Care Testing for Infectious Disease Products, Services and Solutions
7.7.4 BioMerieux Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.7.5 BioMerieux Recent Developments
7.8 ARKRAY
7.8.1 ARKRAY Profile
7.8.2 ARKRAY Main Business
7.8.3 ARKRAY Point of Care Testing for Infectious Disease Products, Services and Solutions
7.8.4 ARKRAY Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.8.5 ARKRAY Recent Developments
7.9 Sinocare
7.9.1 Sinocare Profile
7.9.2 Sinocare Main Business
7.9.3 Sinocare Point of Care Testing for Infectious Disease Products, Services and Solutions
7.9.4 Sinocare Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.9.5 Sinocare Recent Developments
7.10 Wondfo
7.10.1 Wondfo Profile
7.10.2 Wondfo Main Business
7.10.3 Wondfo Point of Care Testing for Infectious Disease Products, Services and Solutions
7.10.4 Wondfo Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.10.5 Wondfo Recent Developments
7.11 Yuwell
7.11.1 Yuwell Profile
7.11.2 Yuwell Main Business
7.11.3 Yuwell Point of Care Testing for Infectious Disease Products, Services and Solutions
7.11.4 Yuwell Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.11.5 Yuwell Recent Developments
7.12 Runbio
7.12.1 Runbio Profile
7.12.2 Runbio Main Business
7.12.3 Runbio Point of Care Testing for Infectious Disease Products, Services and Solutions
7.12.4 Runbio Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.12.5 Runbio Recent Developments
7.13 KHB
7.13.1 KHB Profile
7.13.2 KHB Main Business
7.13.3 KHB Point of Care Testing for Infectious Disease Products, Services and Solutions
7.13.4 KHB Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2019-2024)
7.13.5 KHB Recent Developments
8 Industry Chain Analysis
8.1 Point of Care Testing for Infectious Disease Industrial Chain
8.2 Point of Care Testing for Infectious Disease Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Point of Care Testing for Infectious Disease Sales Model
8.5.2 Sales Channel
8.5.3 Point of Care Testing for Infectious Disease Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Point of Care Testing for Infectious Disease Market Trends
    Table 2. Point of Care Testing for Infectious Disease Market Drivers & Opportunity
    Table 3. Point of Care Testing for Infectious Disease Market Challenges
    Table 4. Point of Care Testing for Infectious Disease Market Restraints
    Table 5. Global Point of Care Testing for Infectious Disease Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Point of Care Testing for Infectious Disease Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Point of Care Testing for Infectious Disease Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Point of Care Testing for Infectious Disease Product Type
    Table 9. Key Companies Time to Begin Mass Production of Point of Care Testing for Infectious Disease
    Table 10. Global Point of Care Testing for Infectious Disease Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Testing for Infectious Disease as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Point of Care Testing for Infectious Disease Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Point of Care Testing for Infectious Disease Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Point of Care Testing for Infectious Disease Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Point of Care Testing for Infectious Disease Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Point of Care Testing for Infectious Disease Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Point of Care Testing for Infectious Disease Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Point of Care Testing for Infectious Disease Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Point of Care Testing for Infectious Disease Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Point of Care Testing for Infectious Disease Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Point of Care Testing for Infectious Disease Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Point of Care Testing for Infectious Disease Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Point of Care Testing for Infectious Disease Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Point of Care Testing for Infectious Disease Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Point of Care Testing for Infectious Disease Sales Value by Region (2019-2024) & (%)
    Table 27. Global Point of Care Testing for Infectious Disease Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Basic Information List
    Table 32. Roche Description and Business Overview
    Table 33. Roche Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Roche (2019-2024)
    Table 35. Roche Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. LifeScan Basic Information List
    Table 42. LifeScan Description and Business Overview
    Table 43. LifeScan Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of LifeScan (2019-2024)
    Table 45. LifeScan Recent Developments
    Table 46. Siemens Healthineers Basic Information List
    Table 47. Siemens Healthineers Description and Business Overview
    Table 48. Siemens Healthineers Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Siemens Healthineers (2019-2024)
    Table 50. Siemens Healthineers Recent Developments
    Table 51. Danaher Basic Information List
    Table 52. Danaher Description and Business Overview
    Table 53. Danaher Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Danaher (2019-2024)
    Table 55. Danaher Recent Developments
    Table 56. Ascensia Basic Information List
    Table 57. Ascensia Description and Business Overview
    Table 58. Ascensia Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Ascensia (2019-2024)
    Table 60. Ascensia Recent Developments
    Table 61. BioMerieux Basic Information List
    Table 62. BioMerieux Description and Business Overview
    Table 63. BioMerieux Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of BioMerieux (2019-2024)
    Table 65. BioMerieux Recent Developments
    Table 66. ARKRAY Basic Information List
    Table 67. ARKRAY Description and Business Overview
    Table 68. ARKRAY Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of ARKRAY (2019-2024)
    Table 70. ARKRAY Recent Developments
    Table 71. Sinocare Basic Information List
    Table 72. Sinocare Description and Business Overview
    Table 73. Sinocare Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Sinocare (2019-2024)
    Table 75. Sinocare Recent Developments
    Table 76. Wondfo Basic Information List
    Table 77. Wondfo Description and Business Overview
    Table 78. Wondfo Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Wondfo (2019-2024)
    Table 80. Wondfo Recent Developments
    Table 81. Yuwell Basic Information List
    Table 82. Yuwell Description and Business Overview
    Table 83. Yuwell Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Yuwell (2019-2024)
    Table 85. Yuwell Recent Developments
    Table 86. Runbio Basic Information List
    Table 87. Runbio Description and Business Overview
    Table 88. Runbio Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of Runbio (2019-2024)
    Table 90. Runbio Recent Developments
    Table 91. KHB Basic Information List
    Table 92. KHB Description and Business Overview
    Table 93. KHB Point of Care Testing for Infectious Disease Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Point of Care Testing for Infectious Disease Business of KHB (2019-2024)
    Table 95. KHB Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Point of Care Testing for Infectious Disease Downstream Customers
    Table 99. Point of Care Testing for Infectious Disease Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Point of Care Testing for Infectious Disease Product Picture
    Figure 2. Global Point of Care Testing for Infectious Disease Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 4. Point of Care Testing for Infectious Disease Report Years Considered
    Figure 5. Global Point of Care Testing for Infectious Disease Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Point of Care Testing for Infectious Disease Revenue in 2023
    Figure 7. Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Immunological Test Picture
    Figure 9. Pathogen Nucleic Acid Test Picture
    Figure 10. Global Point of Care Testing for Infectious Disease Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Point of Care Testing for Infectious Disease Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinics
    Figure 14. Product Picture of Others
    Figure 15. Global Point of Care Testing for Infectious Disease Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Point of Care Testing for Infectious Disease Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Point of Care Testing for Infectious Disease Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Point of Care Testing for Infectious Disease Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Point of Care Testing for Infectious Disease Sales Value (%), (2019-2030)
    Figure 28. United States Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Point of Care Testing for Infectious Disease Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Point of Care Testing for Infectious Disease Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Point of Care Testing for Infectious Disease Sales Value by Application (%), 2023 VS 2030
    Figure 49. Point of Care Testing for Infectious Disease Industrial Chain
    Figure 50. Point of Care Testing for Infectious Disease Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS